Abstract

Introduction: Sepsis is a clinical syndrome that has physiologic, biologic, and biochemical abnormalities caused by a dysregulated inflammatory response to infection. The present study aimed to estimate the dose of injection of norepinephrine in micrograms/ kg/min after 12 hours of starting the vasopressor infusion to keep an MAP of above 65 mm Hg.

Materials & Method: The study was done for the period of two years. Patients who were 18 years and above; who were diagnosed with septic shock during their ICU course and whose relatives gave informed written consent were included in the study.

Result: Total of 12 patients were lost during the study period and so in total 100 patients were enrolled for the study. Both the groups were comparable with respect to the MAP (p = 0.655). The norepinephrine dose in group I vs group II at 12 hours was found to be 0.163 ± 0.089 vs 0.396 ± 0.18 μg/kg/min (p <0.001). Reduction in blood lactate concentration in 12 hours was significantly higher in group I [1.479 ± 1.46] than group II [0.08 ± 1.50] mmol/L (p = 0.002). Increase in the urine output of the patients in 12 hours in Group I [0.72 ± 0.44] than group II [0.47 ± 0.460] mL/kg/hour (p = 0.001).

Conclusion: A low-dose continuous infusion of terlipressin may have a significant role in ensuring better organ perfusion, preventing renal injury, and improving the SOFA score of the patients when used in adjunct to norepinephrine, early in the management of septic shock.

• 1.   Neviere R, Parsons PE, Finlay GJ. Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis. Med Intensiva. 2017;41(1):1-14.
• 2.   Mizock BA. The multiple organ dysfunction syndrome. Dis Mon. 2009;55(11):476-526.
• 3.   Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.
• 4.   Gyawali B, Ramakrishna K, Dhamoon AS. Sepsis: The evolution in definition, pathophysiology, and management. SAGE Open Med. 2019;7:2050312119835043.
• 5.   Lesur O, Delile E, Asfar P, Radermacher P. Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions. Ann Intensive Care. 2018;8(1):1-12.
• 6.   Huang P, Guo Y, Li B, Liu Q. Terlipressin versus norepinephrine for septic shock: A systematic review and meta-analysis. Front Pharmacol. 2019;10:1492.
• 7.   Zhu Y, Huang H, Wang Y, Zhang L, Xi X, Du B. Terlipressin for septic shock patients: protocol for a systematic review and meta-analysis. Respir Med. 2023;5(1):7.
• 8.   Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35(1):33-40.
• 9.   Patel S, Metgud R. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study. J Cancer Res Ther. 2015;11(1):119.
• 10.   Mutlu GM, Factor P. Role of vasopressin in the management of septic shock. Intensive Care Med. 2004;30(7):1276-91.
• 11.   Demiselle J, Fage N, Radermacher P, Asfar P. Vasopressin and its analogues in shock states: a review. Ann Intensive Care. 2020;10(1):1-7.
• 12.   Sahoo P, Kothari N, Goyal S, Sharma A, Bhatia PK. Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study. Indian J Crit Care Med. 2022;26(6):669-75.
• 13.   Rudiger A, Singer M. The heart in sepsis: from basic mechanisms to clinical management. Crit Care. 2013;17(3):234.
• 14.   Liu Z, Chen J, Kou Q, Study Group of investigators. Terlipressin versus norepinephrine as infusion in patients with septic shock: A multicentre, randomised, double-blinded trial. Intensive Care Med. 2018;44(10):1816-25.
• 15.   Boyer TD, Sanyal AJ, Garcia-Tsao G, Blei A, Carl D, Bexon AS, et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J Hepatol. 2011;55(2):315-21.

Data Sharing Statement

Funding